Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE3
Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
- Status
- UNKNOWN
- Phase
- PHASE2
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2